Afficher la couverture 'Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients? | del Bello, Arnaud' en grand format
/5

0 avis

Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?

Archive ouverte

del Bello, Arnaud | Marion, Olivier | Izopet, Jacques | Kamar, Nassim

Edité par CCSD ; MDPI -

International audience. Increased mortality due to SARS-CoV-2 infection was observed among solid organ transplant patients. During the pandemic, in order to prevent and treat COVID-19 infections in this context, several innovative procedures and therapies were initiated within a short period of time. A large number of these innovations can be applied and expanded to improve the management of non-COVID-19 infectious diseases in solid organ transplant patients and in the case of a future pandemic. In this vein, the present paper reviews and discusses medical care system adaptation, modification of immunosuppression, adjuvant innovative therapies, the role of laboratory expertise, and the prevention of infections as examples of such innovations.

Suggestions

Du même auteur

Global and donor-specific T cell exhaustion after kidney transplantation : Phenotypic and functional analyses. Caractériser l'épuisement lymphocytaire T global ou donneur-spécifique, après transplantation rénale : analyse phénotypique et fonctionnelle

Archive ouverte | del Bello, Arnaud | CCSD

Kidney transplantation requires the long-term use of immunosuppressive therapy (IT) even if a modification of rejections phenotype with time was previously noted. However, patient and graft survival remain entailed by over-IT (e.g...

Immune Checkpoints in Solid Organ Transplantation

Archive ouverte | del Bello, Arnaud | CCSD

International audience. Allogenic graft acceptance is only achieved by life-long immunosuppression, which comes at the cost of significant toxicity. Clinicians face the challenge of adapting the patients’ treatments...

Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients

Archive ouverte | del Bello, Arnaud | CCSD

International audience. While kidney transplant recipients (KTRs) represent a high-risk population for severe SARS-CoV-2 infection, almost half of them do not develop adequate levels of antibodies conferring clinica...

Chargement des enrichissements...